← Open Payments lookup

TABITHA PITTMAN: Open Payments

NPI 1184203192 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$324 in 20 payments from 10 companies in 2025. Trend: 2023 $406 · 2024 $92 · 2025 $324

Food & beverage: $324
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$68
ABBVIE INC.4$59
Novo Nordisk Inc4$58
Lilly USA, LLC2$30
Collegium Pharmaceutical, Inc.1$22
Dexcom, Inc.1$20
Neurocrine BioSciences, Inc.1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
GlaxoSmithKline, LLC.1$16
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: CAPLYTA, JARDIANCE, VRAYLAR, Jornay PM, Dexcom G6 Transmitter, INGREZZA, XIFAXAN, LINZESS.

Industry payments across IN — which companies pay providers there.